Evaluating online learning engagement of nursing students

Stephen L. Chan(Chinese University of Hong Kong), John Tai Chun Fung(University of Hong Kong), Chin‐Hsi Lin(University of Hong Kong), Pui Hing Chau(University of Hong Kong), Naomi Takemura(University of Hong Kong)

Nurse Education Today

May 25, 2021

10.1016/j.nedt.2021.104985

Cited by 114

Related Papers

Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma

|NEJM Evidence|2022|1.4k

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial

|The Lancet|2023|1k

Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients

|Proceedings of the National Academy of Sciences|2015|755

Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma

|Liver International|2019|591

Phase 3 randomized, open-label, multicenter study of tremelimumab (T) and durvalumab (D) as first-line therapy in patients (pts) with unresectable hepatocellular carcinoma (uHCC): HIMALAYA.

|Journal of Clinical Oncology|2022|398